Ignite Creation Date:
2024-05-06 @ 4:14 PM
Last Modification Date:
2024-10-26 @ 2:06 PM
Study NCT ID:
NCT04920747
Status:
COMPLETED
Last Update Posted:
2021-06-10
First Post:
2021-06-04
Brief Title:
Interest of the Addition of Docetaxel to Standard Treatment in First-line Advanced HER2 Positive Gastroesophageal Adenocarcinoma in Selective Patients
Sponsor:
Organization:
Centre Hospitalier Universitaire de Besancon